Sterile inflammation: sensing and reacting to damage.

Protective and pathogenic functions of macrophage subsets. Nat Rev Immunol (2011) 12.21

Neutrophil recruitment and function in health and inflammation. Nat Rev Immunol (2013) 7.10

Ischemia and reperfusion--from mechanism to translation. Nat Med (2011) 6.64

Sensing and reacting to microbes through the inflammasomes. Nat Immunol (2012) 5.24

Macrophage-mediated inflammation in metabolic disease. Nat Rev Immunol (2011) 4.68

ROS function in redox signaling and oxidative stress. Curr Biol (2014) 3.35

Mitochondria in innate immune responses. Nat Rev Immunol (2011) 3.31

Microglial cell origin and phenotypes in health and disease. Nat Rev Immunol (2011) 3.20

Mesenchymal stem/stromal cells (MSCs): role as guardians of inflammation. Mol Ther (2011) 3.06

Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME. Arch Toxicol (2013) 3.00

The neutrophil in vascular inflammation. Nat Med (2011) 2.84

Inflammasomes: mechanism of action, role in disease, and therapeutics. Nat Med (2015) 2.59

Many stimuli pull the necrotic trigger, an overview. Cell Death Differ (2011) 2.55

Nucleic acid sensing at the interface between innate and adaptive immunity in vaccination. Nat Rev Immunol (2012) 2.48

Capillary and arteriolar pericytes attract innate leukocytes exiting through venules and 'instruct' them with pattern-recognition and motility programs. Nat Immunol (2012) 2.45

ASC/caspase-1/IL-1β signaling triggers inflammatory responses by promoting HMGB1 induction in liver ischemia/reperfusion injury. Hepatology (2013) 2.45

Dendritic cells limit fibroinflammatory injury in nonalcoholic steatohepatitis in mice. Hepatology (2013) 2.42

Transcranial amelioration of inflammation and cell death after brain injury. Nature (2013) 2.34

STING-Dependent Cytosolic DNA Sensing Promotes Radiation-Induced Type I Interferon-Dependent Antitumor Immunity in Immunogenic Tumors. Immunity (2014) 2.28

Perivascular macrophages mediate neutrophil recruitment during bacterial skin infection. Nat Immunol (2013) 2.22

Two independent pathways of regulated necrosis mediate ischemia-reperfusion injury. Proc Natl Acad Sci U S A (2013) 2.10

Multifarious roles of sialic acids in immunity. Ann N Y Acad Sci (2012) 2.09

The immunology of acute stroke. Nat Rev Neurol (2012) 2.06

Diameter and rigidity of multiwalled carbon nanotubes are critical factors in mesothelial injury and carcinogenesis. Proc Natl Acad Sci U S A (2011) 2.01

CD47 blockade triggers T cell-mediated destruction of immunogenic tumors. Nat Med (2015) 1.98

RIP1-driven autoinflammation targets IL-1α independently of inflammasomes and RIP3. Nature (2013) 1.98

Endogenous histones function as alarmins in sterile inflammatory liver injury through Toll-like receptor 9 in mice. Hepatology (2011) 1.94

Peroxiredoxin family proteins are key initiators of post-ischemic inflammation in the brain. Nat Med (2012) 1.90

Trial Watch: Experimental Toll-like receptor agonists for cancer therapy. Oncoimmunology (2012) 1.88

An inherited mutation in NLRC4 causes autoinflammation in human and mice. J Exp Med (2014) 1.86

Sclerotic-type chronic GVHD of the skin: clinical risk factors, laboratory markers, and burden of disease. Blood (2011) 1.83

Macrophage phenotype as a predictor of constructive remodeling following the implantation of biologically derived surgical mesh materials. Acta Biomater (2011) 1.81

Role of innate immunity and the microbiota in liver fibrosis: crosstalk between the liver and gut. J Physiol (2011) 1.79

Cell death and cell death responses in liver disease: mechanisms and clinical relevance. Gastroenterology (2014) 1.73

Cell death and infection: a double-edged sword for host and pathogen survival. J Cell Biol (2011) 1.69

Chemokines in health and disease. Exp Cell Res (2011) 1.69

Host innate immune responses to sepsis. Virulence (2013) 1.66

Exploring the neuroimmunopharmacology of opioids: an integrative review of mechanisms of central immune signaling and their implications for opioid analgesia. Pharmacol Rev (2011) 1.66

Emerging mechanisms of neutrophil recruitment across endothelium. Trends Immunol (2011) 1.65

The vagus nerve and the inflammatory reflex--linking immunity and metabolism. Nat Rev Endocrinol (2012) 1.59

Metabolic reprogramming in macrophages and dendritic cells in innate immunity. Cell Res (2015) 1.53

Mitochondria and cell signalling. J Cell Sci (2012) 1.52

Inflammation, endoplasmic reticulum stress, autophagy, and the monocyte chemoattractant protein-1/CCR2 pathway. Circ Res (2012) 1.51

Signaling by the matrix proteoglycan decorin controls inflammation and cancer through PDCD4 and MicroRNA-21. Sci Signal (2011) 1.50

Effect of beta-blocker therapy on the risk of infections and death after acute stroke--a historical cohort study. PLoS One (2015) 1.49

Extracellular Ca2+ is a danger signal activating the NLRP3 inflammasome through G protein-coupled calcium sensing receptors. Nat Commun (2012) 1.48

Caspase-1: is IL-1 just the tip of the ICEberg? Cell Death Dis (2012) 1.47

Divergent effects of Tlr9 deletion in experimental late venous thrombosis resolution and vein wall injury. Thromb Haemost (2015) 1.43

Platelet-rich plasma for managing pain and inflammation in osteoarthritis. Nat Rev Rheumatol (2013) 1.43

NADPH oxidase controls neutrophilic response to sterile inflammation in mice by regulating the IL-1α/G-CSF axis. Blood (2015) 1.41

Innate and adaptive immune responses to cell death. Immunol Rev (2011) 1.40

The danger theory: 20 years later. Front Immunol (2012) 1.38

Fungal antioxidant pathways promote survival against neutrophils during infection. J Clin Invest (2012) 1.37

The HMGB1/RAGE axis triggers neutrophil-mediated injury amplification following necrosis. J Clin Invest (2014) 1.35

Trial Watch: Toll-like receptor agonists for cancer therapy. Oncoimmunology (2013) 1.35

The role of inflammation in perinatal brain injury. Nat Rev Neurol (2015) 1.35

Medical therapies with adult stem/progenitor cells (MSCs): a backward journey from dramatic results in vivo to the cellular and molecular explanations. J Cell Biochem (2012) 1.33

Since there are PAMPs and DAMPs, there must be SAMPs? Glycan “self-associated molecular patterns” dampen innate immunity, but pathogens can mimic them. Glycobiology (2011) 1.33

NLRP3-Inflammasome Activating DAMPs Stimulate an Inflammatory Response in Glia in the Absence of Priming Which Contributes to Brain Inflammation after Injury. Front Immunol (2012) 1.33

Complexity of danger: the diverse nature of damage-associated molecular patterns. J Biol Chem (2014) 1.32

A novel molecular microbiologic technique for the rapid diagnosis of microbial invasion of the amniotic cavity and intra-amniotic infection in preterm labor with intact membranes. Am J Reprod Immunol (2014) 1.32

The biological basis of injury and neuroprotection in the fetal and neonatal brain. Int J Dev Neurosci (2011) 1.31

Uric acid as a danger signal in gout and its comorbidities. Nat Rev Rheumatol (2012) 1.31

Trial watch: FDA-approved Toll-like receptor agonists for cancer therapy. Oncoimmunology (2012) 1.30

Inflammasomes in intestinal inflammation and cancer. Gastroenterology (2011) 1.28

Perioperative organ injury. Anesthesiology (2013) 1.27

New approaches to the study of sepsis. EMBO Mol Med (2012) 1.27

Intracellular interleukin-1 receptor 2 binding prevents cleavage and activity of interleukin-1α, controlling necrosis-induced sterile inflammation. Immunity (2013) 1.26

Induction of inflammasome-dependent pyroptosis by carbon black nanoparticles. J Biol Chem (2011) 1.25

Activation of NLRP3 inflammasome in alveolar macrophages contributes to mechanical stretch-induced lung inflammation and injury. J Immunol (2013) 1.24

A new eye on NLR proteins: focused on clarity or diffused by complexity? Curr Opin Immunol (2012) 1.24

Innate immunity and coagulation. J Thromb Haemost (2011) 1.24

Biological interplay between proteoglycans and their innate immune receptors in inflammation. FEBS J (2013) 1.22

The innate immune response to products of phospholipid peroxidation. Biochim Biophys Acta (2012) 1.20

TSG-6 as a biomarker to predict efficacy of human mesenchymal stem/progenitor cells (hMSCs) in modulating sterile inflammation in vivo. Proc Natl Acad Sci U S A (2014) 1.19

TXNIP links innate host defense mechanisms to oxidative stress and inflammation in retinal Muller glia under chronic hyperglycemia: implications for diabetic retinopathy. Exp Diabetes Res (2012) 1.19

Myeloid-related protein-14 contributes to protective immunity in gram-negative pneumonia derived sepsis. PLoS Pathog (2012) 1.19

Noninvasive molecular imaging of neuroinflammation. J Cereb Blood Flow Metab (2012) 1.19

Cholesterol regulation of receptor-interacting protein 140 via microRNA-33 in inflammatory cytokine production. FASEB J (2011) 1.18

Targeting the "cytokine storm" for therapeutic benefit. Clin Vaccine Immunol (2013) 1.17

Acute chorioamnionitis and funisitis: definition, pathologic features, and clinical significance. Am J Obstet Gynecol (2015) 1.16

A Genome-wide CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) Screen Identifies NEK7 as an Essential Component of NLRP3 Inflammasome Activation. J Biol Chem (2015) 1.15

Sterile inflammatory response in acute pancreatitis. Pancreas (2012) 1.15

Functional diversity of microglia - how heterogeneous are they to begin with? Front Cell Neurosci (2013) 1.14

Microglial M1/M2 polarization and metabolic states. Br J Pharmacol (2015) 1.14

Tumour inflammasome-derived IL-1β recruits neutrophils and improves local recurrence-free survival in EBV-induced nasopharyngeal carcinoma. EMBO Mol Med (2012) 1.14

Inflammasome activation and function in liver disease. Nat Rev Gastroenterol Hepatol (2015) 1.13

Biglycan: a multivalent proteoglycan providing structure and signals. J Histochem Cytochem (2012) 1.12

The NLRP3 Inflammasome as a novel player of the intercellular crosstalk in metabolic disorders. Mediators Inflamm (2013) 1.11

Small leucine-rich proteoglycans orchestrate receptor crosstalk during inflammation. Cell Cycle (2012) 1.11

DAMPs from Cell Death to New Life. Front Immunol (2015) 1.11

Cellular stress response and innate immune signaling: integrating pathways in host defense and inflammation. J Leukoc Biol (2013) 1.10

Expanding the clinical indications for α(1)-antitrypsin therapy. Mol Med (2012) 1.10

Microglial activation and antioxidant responses induced by the Parkinson's disease protein α-synuclein. J Neuroimmune Pharmacol (2012) 1.09

Interleukin-1 receptor antagonist is beneficial after subarachnoid haemorrhage in rat by blocking haem-driven inflammatory pathology. Dis Model Mech (2012) 1.09

The p38α MAPK regulates microglial responsiveness to diffuse traumatic brain injury. J Neurosci (2013) 1.08

Inflection points in sepsis biology: from local defense to systemic organ injury. Am J Physiol Lung Cell Mol Physiol (2012) 1.06

Nonconvulsive seizures in subarachnoid hemorrhage link inflammation and outcome. Ann Neurol (2014) 1.06

A case of mistaken identity: HSPs are no DAMPs but DAMPERs. Cell Stress Chaperones (2011) 1.06

Apoptosis and necrosis in the liver. Compr Physiol (2013) 1.05

Atherosclerosis--an inflammatory disease. N Engl J Med (1999) 59.28

Inflammation and cancer. Nature (2002) 53.78

Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell (2004) 29.32

Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature (2006) 24.43

Pattern recognition receptors and inflammation. Cell (2010) 21.05

Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature (2002) 19.77

Inflammation and insulin resistance. J Clin Invest (2006) 18.76

Cryopyrin activates the inflammasome in response to toxins and ATP. Nature (2006) 18.74

TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest (2006) 17.49

Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization. Nat Immunol (2008) 16.65

Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica. Science (2008) 16.54

Tolerance, danger, and the extended family. Annu Rev Immunol (1994) 14.94

Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy. Nat Med (2007) 13.90

AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC. Nature (2009) 13.23

Interleukin-1-receptor antagonist in type 2 diabetes mellitus. N Engl J Med (2007) 11.62

Altered cytokine export and apoptosis in mice deficient in interleukin-1 beta converting enzyme. Science (1995) 11.38

Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature (2010) 11.24

AIM2 activates the inflammasome and cell death in response to cytoplasmic DNA. Nature (2009) 10.83

NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature (2010) 10.60

Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009. Cell Death Differ (2008) 10.45

The NALP3 inflammasome is involved in the innate immune response to amyloid-beta. Nat Immunol (2008) 10.39

Thioredoxin-interacting protein links oxidative stress to inflammasome activation. Nat Immunol (2009) 9.24

Mice deficient in IL-1 beta-converting enzyme are defective in production of mature IL-1 beta and resistant to endotoxic shock. Cell (1995) 9.11

IFI16 is an innate immune sensor for intracellular DNA. Nat Immunol (2010) 8.97

Molecular identification of a danger signal that alerts the immune system to dying cells. Nature (2003) 8.90

Activation of the NALP3 inflammasome is triggered by low intracellular potassium concentration. Cell Death Differ (2007) 8.85

How dying cells alert the immune system to danger. Nat Rev Immunol (2008) 8.63

RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides. Cell (1999) 8.55

Regulation of lung injury and repair by Toll-like receptors and hyaluronan. Nat Med (2005) 8.49

Cutting edge: NF-kappaB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression. J Immunol (2009) 8.40

Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE. Nat Immunol (2007) 8.33

Pannexin-1 mediates large pore formation and interleukin-1beta release by the ATP-gated P2X7 receptor. EMBO J (2006) 8.12

An orthogonal proteomic-genomic screen identifies AIM2 as a cytoplasmic DNA sensor for the inflammasome. Nat Immunol (2009) 7.93

The AIM2 inflammasome is essential for host defense against cytosolic bacteria and DNA viruses. Nat Immunol (2010) 7.47

Identification of a key pathway required for the sterile inflammatory response triggered by dying cells. Nat Med (2007) 7.25

RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease. Nature (1996) 7.04

Activation of the NLRP3 inflammasome in dendritic cells induces IL-1beta-dependent adaptive immunity against tumors. Nat Med (2009) 6.73

Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasis. Nature (2009) 6.67

Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1β in type 2 diabetes. Nat Immunol (2010) 6.64

Active caspase-1 is a regulator of unconventional protein secretion. Cell (2008) 5.89

CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer. Nat Immunol (2009) 5.87

The AIM2 inflammasome is critical for innate immunity to Francisella tularensis. Nat Immunol (2010) 5.79

HMGB1 and RAGE in inflammation and cancer. Annu Rev Immunol (2010) 5.65

The Nalp3 inflammasome is essential for the development of silicosis. Proc Natl Acad Sci U S A (2008) 5.59

Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E. Proc Natl Acad Sci U S A (2004) 5.58

The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and co-expression of rage and amphoterin in the developing nervous system. J Biol Chem (1995) 5.36

CD36 is a sensor of diacylglycerides. Nature (2005) 5.20

Acetaminophen-induced hepatotoxicity in mice is dependent on Tlr9 and the Nalp3 inflammasome. J Clin Invest (2009) 5.09

IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo. Proc Natl Acad Sci U S A (2006) 5.08

CD24 and Siglec-10 selectively repress tissue damage-induced immune responses. Science (2009) 5.00

Signalling through C-type lectin receptors: shaping immune responses. Nat Rev Immunol (2009) 4.98

Mechanisms in the pathogenesis of asbestosis and silicosis. Am J Respir Crit Care Med (1998) 4.72

Mincle is an ITAM-coupled activating receptor that senses damaged cells. Nat Immunol (2008) 4.66

A pilot study of IL-1 inhibition by anakinra in acute gout. Arthritis Res Ther (2007) 4.65

HMGB1 signals through toll-like receptor (TLR) 4 and TLR2. Shock (2006) 4.53

Inflammatory cells during wound repair: the good, the bad and the ugly. Trends Cell Biol (2005) 4.53

The IL-1-like cytokine IL-33 is constitutively expressed in the nucleus of endothelial cells and epithelial cells in vivo: a novel 'alarmin'? PLoS One (2008) 4.52

Suppression of interleukin-33 bioactivity through proteolysis by apoptotic caspases. Immunity (2009) 4.49

Necrotic but not apoptotic cell death releases heat shock proteins, which deliver a partial maturation signal to dendritic cells and activate the NF-kappa B pathway. Int Immunol (2000) 4.48

mRNA is an endogenous ligand for Toll-like receptor 3. J Biol Chem (2004) 4.43

ATP activates a reactive oxygen species-dependent oxidative stress response and secretion of proinflammatory cytokines in macrophages. J Biol Chem (2006) 4.33

Reduced atherosclerosis in MyD88-null mice links elevated serum cholesterol levels to activation of innate immunity signaling pathways. Nat Med (2004) 4.29

CD91 is a common receptor for heat shock proteins gp96, hsp90, hsp70, and calreticulin. Immunity (2001) 4.16

Necrotic cells trigger a sterile inflammatory response through the Nlrp3 inflammasome. Proc Natl Acad Sci U S A (2009) 3.99

The matrix component biglycan is proinflammatory and signals through Toll-like receptors 4 and 2 in macrophages. J Clin Invest (2005) 3.99

Identification of a dendritic cell receptor that couples sensing of necrosis to immunity. Nature (2009) 3.93

Adenosine 5'-triphosphate and adenosine as endogenous signaling molecules in immunity and inflammation. Pharmacol Ther (2006) 3.93

Modulation of atherosclerosis in mice by Toll-like receptor 2. J Clin Invest (2005) 3.91

Activation of pannexin 1 channels by ATP through P2Y receptors and by cytoplasmic calcium. FEBS Lett (2005) 3.89

Hyaluronan in tissue injury and repair. Annu Rev Cell Dev Biol (2007) 3.62

TLR3 is an endogenous sensor of tissue necrosis during acute inflammatory events. J Exp Med (2008) 3.62

Hepatocyte necrosis induced by oxidative stress and IL-1 alpha release mediate carcinogen-induced compensatory proliferation and liver tumorigenesis. Cancer Cell (2008) 3.58

C-type lectin receptors on dendritic cells and Langerhans cells. Nat Rev Immunol (2002) 3.44

The IL-1-like cytokine IL-33 is inactivated after maturation by caspase-1. Proc Natl Acad Sci U S A (2009) 3.39

Receptor-mediated monitoring of tissue well-being via detection of soluble heparan sulfate by Toll-like receptor 4. J Immunol (2002) 3.32

Hyaluronan fragments act as an endogenous danger signal by engaging TLR2. J Immunol (2006) 3.32

Cutting edge: TNF-alpha mediates sensitization to ATP and silica via the NLRP3 inflammasome in the absence of microbial stimulation. J Immunol (2009) 3.32

Caspase-1 independent IL-1beta production is critical for host resistance to mycobacterium tuberculosis and does not require TLR signaling in vivo. J Immunol (2010) 3.25

Endocytosed HSP60s use toll-like receptor 2 (TLR2) and TLR4 to activate the toll/interleukin-1 receptor signaling pathway in innate immune cells. J Biol Chem (2001) 3.16

Vascular and inflammatory stresses mediate atherosclerosis via RAGE and its ligands in apoE-/- mice. J Clin Invest (2008) 3.11

IL-1 pathways in inflammation and human diseases. Nat Rev Rheumatol (2010) 2.99

Binding of the Drosophila cytokine Spätzle to Toll is direct and establishes signaling. Nat Immunol (2003) 2.99

Interleukin-1 mitogenic activity for fibroblasts and smooth muscle cells is due to PDGF-AA. Science (1989) 2.98

Reactive oxygen species (ROS) and reactive nitrogen species (RNS) generation by silica in inflammation and fibrosis. Free Radic Biol Med (2003) 2.94

Malarial hemozoin is a Nalp3 inflammasome activating danger signal. PLoS One (2009) 2.93

Pivotal advance: analysis of proinflammatory activity of highly purified eukaryotic recombinant HMGB1 (amphoterin). J Leukoc Biol (2006) 2.88

Recognition of hyaluronan released in sterile injury involves a unique receptor complex dependent on Toll-like receptor 4, CD44, and MD-2. J Biol Chem (2007) 2.82

Pannexin-1-mediated intracellular delivery of muramyl dipeptide induces caspase-1 activation via cryopyrin/NLRP3 independently of Nod2. J Immunol (2008) 2.65

Sustained effects of interleukin-1 receptor antagonist treatment in type 2 diabetes. Diabetes Care (2009) 2.56

Myd88-dependent positioning of Ptgs2-expressing stromal cells maintains colonic epithelial proliferation during injury. J Clin Invest (2007) 2.55

Innate immunity conferred by Toll-like receptors 2 and 4 and myeloid differentiation factor 88 expression is pivotal to monosodium urate monohydrate crystal-induced inflammation. Arthritis Rheum (2005) 2.48

Caspase 1-independent IL-1beta release and inflammation induced by the apoptosis inducer Fas ligand. Nat Med (1998) 2.47

Receptor for advanced glycation end products (RAGE) deficiency attenuates the development of atherosclerosis in diabetes. Diabetes (2008) 2.41

Immunology and immunotherapy of Alzheimer's disease. Nat Rev Immunol (2006) 2.33

Wound healing: the role of the macrophage and other immune cells. Shock (1995) 2.26

Cutting edge: critical role for mesothelial cells in necrosis-induced inflammation through the recognition of IL-1 alpha released from dying cells. J Immunol (2008) 2.13

Biglycan, a danger signal that activates the NLRP3 inflammasome via toll-like and P2X receptors. J Biol Chem (2009) 2.12

Response to local inflammation of IL-1 beta-converting enzyme- deficient mice. J Immunol (1997) 2.10

Endotoxin contamination in recombinant human heat shock protein 70 (Hsp70) preparation is responsible for the induction of tumor necrosis factor alpha release by murine macrophages. J Biol Chem (2002) 2.06

Differential release of chromatin-bound IL-1alpha discriminates between necrotic and apoptotic cell death by the ability to induce sterile inflammation. Proc Natl Acad Sci U S A (2010) 2.04

Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract. Science (2005) 11.31

NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature (2010) 10.60

Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohn's disease. J Biol Chem (2003) 9.37

The inflammasome: a caspase-1-activation platform that regulates immune responses and disease pathogenesis. Nat Immunol (2009) 7.80

Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1β in type 2 diabetes. Nat Immunol (2010) 6.64

An essential role for NOD1 in host recognition of bacterial peptidoglycan containing diaminopimelic acid. Nat Immunol (2003) 6.46

NOD-LRR proteins: role in host-microbial interactions and inflammatory disease. Annu Rev Biochem (2005) 6.18

Nod1 and Nod2 direct autophagy by recruiting ATG16L1 to the plasma membrane at the site of bacterial entry. Nat Immunol (2009) 5.83

NODs: intracellular proteins involved in inflammation and apoptosis. Nat Rev Immunol (2003) 5.07

Differential regulation of caspase-1 activation, pyroptosis, and autophagy via Ipaf and ASC in Shigella-infected macrophages. PLoS Pathog (2007) 4.73

NOD-like receptors: role in innate immunity and inflammatory disease. Annu Rev Pathol (2009) 3.39

A requirement for CARMA1 in TCR-induced NF-kappa B activation. Nat Immunol (2002) 3.38

Function of Nod-like receptors in microbial recognition and host defense. Immunol Rev (2009) 3.20

Crohn's disease and the NOD2 gene: a role for paneth cells. Gastroenterology (2003) 2.72

Crohn's disease-associated NOD2 variants share a signaling defect in response to lipopolysaccharide and peptidoglycan. Gastroenterology (2003) 2.64

NOD-like receptors (NLRs): bona fide intracellular microbial sensors. Curr Opin Immunol (2008) 2.45

Immunogenicity of whole-parasite vaccines against Plasmodium falciparum involves malarial hemozoin and host TLR9. Cell Host Microbe (2010) 2.03

CARMA3/Bcl10/MALT1-dependent NF-kappaB activation mediates angiotensin II-responsive inflammatory signaling in nonimmune cells. Proc Natl Acad Sci U S A (2006) 1.96

Nods: a family of cytosolic proteins that regulate the host response to pathogens. Curr Opin Microbiol (2002) 1.93

ML -- a conserved domain involved in innate immunity and lipid metabolism. Trends Biochem Sci (2002) 1.92

A role for Erbin in the regulation of Nod2-dependent NF-kappaB signaling. J Biol Chem (2005) 1.81

T cell-intrinsic role of Nod2 in promoting type 1 immunity to Toxoplasma gondii. Nat Immunol (2009) 1.67

Differential release and distribution of Nod1 and Nod2 immunostimulatory molecules among bacterial species and environments. J Biol Chem (2006) 1.55

Nucleotide-binding oligomerization domain-1 and epidermal growth factor receptor: critical regulators of beta-defensins during Helicobacter pylori infection. J Biol Chem (2006) 1.30

Peptidoglycan signaling in innate immunity and inflammatory disease. J Biol Chem (2005) 1.25

A deficiency in the autophagy gene Atg16L1 enhances resistance to enteric bacterial infection. Cell Host Microbe (2013) 1.21

Cytokines tumor necrosis factor-α and interferon-γ induce pancreatic β-cell apoptosis through STAT1-mediated Bim protein activation. J Biol Chem (2011) 1.20

Critical role for DP5/Harakiri, a Bcl-2 homology domain 3-only Bcl-2 family member, in axotomy-induced neuronal cell death. J Neurosci (2004) 1.18

TLR4-mediated AKT activation is MyD88/TRIF dependent and critical for induction of oxidative phosphorylation and mitochondrial transcription factor A in murine macrophages. J Immunol (2012) 1.18

A novel caspase-1/toll-like receptor 4-independent pathway of cell death induced by cytosolic Shigella in infected macrophages. J Biol Chem (2005) 1.16

Dysfunctional apoptosome activation in ovarian cancer: implications for chemoresistance. Cancer Res (2002) 1.13

Crystal structure of the Nod1 caspase activation and recruitment domain. Biochem Biophys Res Commun (2006) 1.10

The ever-expanding function of NOD2: autophagy, viral recognition, and T cell activation. Trends Immunol (2011) 1.09

Porphyromonas gingivalis oral infection exacerbates the development and severity of collagen-induced arthritis. Arthritis Res Ther (2013) 1.05

Genetic variation and activity of mouse Nod2, a susceptibility gene for Crohn's disease. Genomics (2003) 1.04

Apoptosome formation and caspase activation: is it different in the heart? J Mol Cell Cardiol (2004) 1.04

Mechanism of impaired NLRP3 inflammasome priming by monophosphoryl lipid A. Sci Signal (2011) 1.03

A role of lipophilic peptidoglycan-related molecules in induction of Nod1-mediated immune responses. J Biol Chem (2007) 1.01

Membrane damage during Listeria monocytogenes infection triggers a caspase-7 dependent cytoprotective response. PLoS Pathog (2012) 0.97

Roles for homotypic interactions and transautophosphorylation in IkappaB kinase beta IKKbeta) activation [corrected]. J Biol Chem (2003) 0.96

Nod1/Nod2-mediated recognition plays a critical role in induction of adaptive immunity to anthrax after aerosol exposure. Infect Immun (2009) 0.95

A dual role for receptor-interacting protein kinase 2 (RIP2) kinase activity in nucleotide-binding oligomerization domain 2 (NOD2)-dependent autophagy. J Biol Chem (2012) 0.94

The nucleotide synthesis enzyme CAD inhibits NOD2 antibacterial function in human intestinal epithelial cells. Gastroenterology (2012) 0.88

Both exogenous commensal and endogenous self antigens stimulate T cell proliferation under lymphopenic conditions. Cell Immunol (2011) 0.87

Mindin the fort. Nat Immunol (2004) 0.83

TACI deficiency enhances antibody avidity and clearance of an intestinal pathogen. J Clin Invest (2014) 0.83

Battling enteroinvasive bacteria: Nod1 comes to the rescue. Trends Microbiol (2004) 0.83

AIM2 joins the gang of microbial sensors. Cell Host Microbe (2010) 0.78

Selective Biological Responses of Phagocytes and Lungs to Purified Histones. J Innate Immun (2017) 0.75